These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1819735)

  • 21. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality.
    Libert C; Van Molle W; Brouckaert P; Fiers W
    J Inflamm; 1995-1996; 46(3):139-43. PubMed ID: 8844494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure.
    Anderson BO; Bensard DD; Harken AH
    Surg Gynecol Obstet; 1991 May; 172(5):415-24. PubMed ID: 1851337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock.
    Schurr MJ; Fabian TC; Croce MA; Geraci SA; Proctor KG
    Surgery; 1997 May; 121(5):493-500. PubMed ID: 9142146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
    Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
    J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep.
    Christman BW; Lefferts PL; Blair IA; Snapper JR
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1272-8. PubMed ID: 2174655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats.
    Zhou W; Chao W; Levine BA; Olson MS
    Am J Physiol; 1992 Nov; 263(5 Pt 1):G587-92. PubMed ID: 1443133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of SR 27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shock in mice.
    Herbert JM; Lespy L; Maffrand JP
    Eur J Pharmacol; 1991 Dec; 205(3):271-6. PubMed ID: 1817964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paf antagonists block induction of nitric oxide synthase in cultured macrophages and vascular smooth muscle cells.
    Arthur JF; Shahin S; Dusting GJ
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):452-4. PubMed ID: 8582100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thieno-triazolo-1,4-diazepines as antagonists of platelet-activating factor: present status.
    Casals-Stenzel J
    Lipids; 1991 Dec; 26(12):1157-61. PubMed ID: 1668111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is platelet activating factor (PAF) a mediator of endotoxin shock?
    Terashita Z; Imura Y; Nishikawa K; Sumida S
    Eur J Pharmacol; 1985 Feb; 109(2):257-61. PubMed ID: 3996473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of yangambin on cardiovascular hyporeactivity to catecholamines in rats with endotoxin-induced shock.
    Araújo CV; Barbosa-Filho JM; Cordeiro RS; Tibiriçá E
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):267-75. PubMed ID: 11284440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart.
    Hu W; McNicholl IK; Choy PC; Man RY
    Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs.
    Heuer HO
    Lipids; 1991 Dec; 26(12):1374-80. PubMed ID: 1819736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor in cardiovascular stress situations.
    Rabinovici R; Yue TL; Feuerstein G
    Lipids; 1991 Dec; 26(12):1257-63. PubMed ID: 1819713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed treatment with platelet activating factor receptor antagonist web 2086 attenuates pulmonary dysfunction in porcine endotoxin shock.
    Siebeck M; Kohl J; Endres S; Spannagl M; Machleidt W
    J Trauma; 1994 Nov; 37(5):745-51. PubMed ID: 7966471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compounds biologically similar to platelet activating factor are present in stored blood components.
    Silliman CC; Johnson CA; Clay KL; Thurman GW; Ambruso DR
    Lipids; 1993 May; 28(5):415-8. PubMed ID: 8316049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments.
    Bahrami S; Redl H; Thurnher M; Vogl C; Paul E; Schiesser A; Schlag G
    Prog Clin Biol Res; 1989; 308():931-6. PubMed ID: 2780740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.